Article Details
Retrieved on: 2021-04-13 12:00:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
But that's where we stand for therapeutics, and all 3 of those therapeutic monoclonal antibodies have additional biosimilars in the pipeline. Clearly ...
Article found on: www.pharmacytimes.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here